TSS
SAGE

Two Sigma Securities’s Sage Therapeutics SAGE Stock Holding History

Two Sigma Securities’s Portfolio SAGE Stock Details SAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-11,714
Closed -$107K – 1918
2025
Q2 		$107K Buy
+11,714
New +$86.2K 0.01% 1035
2020
Q1 		– Sell
-3,882
Closed -$280K – 2158
2019
Q4 		$280K Buy
+3,882
New +$478K ﹤0.01% 1844
2017
Q3 		– Sell
-3,081
Closed -$245K – 1181
2017
Q2 		$245K Buy
+3,081
New +$223K 0.05% 439

Other funds holding SAGE

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Two Sigma Securities's SAGE Position: Q3 2025 in Review

Two Sigma Securities sold out of Sage Therapeutics (SAGE) in Q3 2025, closing a stake of 11,714 shares — an estimated $107K sold.

Two Sigma Securities first reported a position in SAGE in Q2 2017 and held it in 3 quarters. The position peaked at $280K in Q4 2019. 5 funds tracked by Wall St. Rank hold SAGE as of Q3 2025.

  • Two Sigma Securities reported no remaining Sage Therapeutics position as of Q3 2025 after selling out during the quarter.
  • Two Sigma Securities sold 11,714 Sage Therapeutics shares in Q3 2025, an estimated $107K.
  • Two Sigma Securities first reported a position in Sage Therapeutics in Q2 2017 and held it in 3 quarters.
  • Two Sigma Securities's Sage Therapeutics position peaked at $280K in Q4 2019.
  • 5 funds tracked by Wall St. Rank held Sage Therapeutics as of Q3 2025.

Based on Two Sigma Securities's 13F filing for Q3 2025, filed 14 Nov 2025.